| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/01/2001 | US6225076 Crystal of bacterial core RNA polymerase and methods of use thereof |
| 05/01/2001 | US6225074 Mixing test sample with reagent solution of chloramphenicol or derivative, an acyl coenzyme a compound, and a tetrazolium salt, then observing optical response; solution does not contain redox enzyme |
| 05/01/2001 | US6225069 Analyzing biological sample for presence of interleukin-1a 2,2 (-889) genotype, interleukin-1b 2,2 (+3953) genotype, or a combination of the two which indicates increased risk for developing the disease |
| 05/01/2001 | US6225068 Simple extraction of individual fluorescent macromolecule from fluid by coating region of fiber tip with binding molecules, dipping tip into fluid, irradiating tip, removing tip when detected fluoresence exceeds predetermined intensity |
| 05/01/2001 | US6225067 Methods and devices for performing analysis of a nucleic acid sample |
| 05/01/2001 | US6225066 Determining drug resistance by incubating strain with drug and temperate mycobacteriophage permiting formation of lysogens which express reporter gene, then detecting transcription of reporter gene as indicator of resistance |
| 05/01/2001 | US6225065 Kit for amplifying nucleic acid |
| 05/01/2001 | US6225064 Ligating oligonucleotides to 3' termini of sample dna fragment groups, mixing ligated products together, amplifying using polymerase chain reaction and primers complementary to oligonucleotides, and detecting; comparison of plural samples |
| 05/01/2001 | US6225063 RNA channels in biological membranes |
| 05/01/2001 | US6225062 Simplified one pot process by incubating rna sample, primers, ribonucleotide and deoxyribonucleotide triphosphates, chain terminating nucleotide triphosphates, and rnase h and various polymerases; electrophoresis; identifying terminated products |
| 05/01/2001 | US6225059 Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics |
| 05/01/2001 | US6225058 Mixing paired rna of defined nucleotide sequences with sample, allowing binding of rna with sample to form complex, using rna replicase to produce rna, monitoring for new rna as indication of target molecule |
| 05/01/2001 | US6225057 Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection |
| 05/01/2001 | US6225056 Solid phases for target nucleic acid detection, process for production thereof, and method of target nucleic acid detection |
| 05/01/2001 | US6225055 Apparatus for the parallel alignment of macromolecules, and use thereof |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225053 Detection of hepatitis B virus |
| 05/01/2001 | US6225052 Method for determining a nucleic acid |
| 05/01/2001 | US6225051 An emission layer comprising atleast one receiving compound and an emitting compound which is di, tri or tetravalent metal phthalocyanine or porphine compound |
| 05/01/2001 | US6225049 Human insulinoma-associated cDNA |
| 05/01/2001 | US6225048 Culturing monocytes in fluid communication with viable, allogenically stimulated peripheral blood mononuclear cells to cause differentiation into macrophages, then permitting replication of latent or exogenous virus |
| 05/01/2001 | US6225047 Use of retentate chromatography to generate difference maps |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224865 Suppression of inhibitors |
| 05/01/2001 | CA2075042C Manipulation of solid, semi-solid or liquid materials |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 04/27/2001 | CA2286512A1 Oligonucleotide primers for the specific pcr detection of enterobacteriaceae species dna using rfe-rff gene templates |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029563A1 Method of screening for inhibitors of asp2 |
| 04/26/2001 | WO2001029562A1 A method for the assessment of allergenicity |
| 04/26/2001 | WO2001029561A1 Biochip |
| 04/26/2001 | WO2001029269A2 Gene expression profiling of inflammatory bowel disease |
| 04/26/2001 | WO2001029267A1 Methods for identifying and using maintenance genes |
| 04/26/2001 | WO2001029266A2 Identification of arsacs mutations and methods of use therefor |
| 04/26/2001 | WO2001029265A1 Method of detecting single gene copies in-situ |
| 04/26/2001 | WO2001029264A2 Nucleic acid primers and probes for detecting tumor cells |
| 04/26/2001 | WO2001029263A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene |
| 04/26/2001 | WO2001029262A2 Genotyping reagents, kits and methods of use thereof |
| 04/26/2001 | WO2001029261A2 A method for high-density microarray mediated gene expression profiling |
| 04/26/2001 | WO2001029260A2 Allele detection using primer extension with sequence-coded identity tags |
| 04/26/2001 | WO2001029259A2 Identification of alleles |
| 04/26/2001 | WO2001029258A1 Hybridization probes |
| 04/26/2001 | WO2001029257A2 Methods of genetic cluster analysis |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029254A2 Identification of bpesc1, a gene disrupted by a balanced chromosomal translocation t(3;4) (q23;p15.2) in a patient with bpes |
| 04/26/2001 | WO2001029253A2 Simultaneous visualization of eu- and heterochromatin |
| 04/26/2001 | WO2001029252A2 A method for the generation of repeat-depleted dna |
| 04/26/2001 | WO2001029251A2 Improved mutation analysis of the nf1 gene |
| 04/26/2001 | WO2001029248A2 Method for amplifying and detecting nucleic acid |
| 04/26/2001 | WO2001029240A2 Regeneration |
| 04/26/2001 | WO2001029236A1 Expression system for membrane proteins |
| 04/26/2001 | WO2001029235A2 Tms1 compositions and methods of use |
| 04/26/2001 | WO2001029234A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029214A1 Colon-tumour-associated antigens |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029208A1 Conditional gene trapping construct for the disruption of genes |
| 04/26/2001 | WO2001029207A1 Antiuracil monoclonal antibody |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029176A2 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 3 gene |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029090A1 Immunological assay for detection of antibodies in celiac disease |
| 04/26/2001 | WO2001029082A1 A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 04/26/2001 | WO2001029072A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029069A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | WO2001029068A2 A eag gene encoding for a potassium channel |
| 04/26/2001 | WO2001029064A2 Melanoma antigens and methods of use |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029054A2 Medicaments for treatment of respiratory syncytial virus infections |
| 04/26/2001 | WO2001028995A2 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene |
| 04/26/2001 | WO2001028684A2 System and method for filling a substrate with a liquid sample |
| 04/26/2001 | WO2001028683A1 Disposable test devices for performing nucleic acid amplification reactions |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028579A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | WO2001028577A2 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 04/26/2001 | WO2001028500A2 Uses of antileukoprotease in carcinoma |
| 04/26/2001 | WO2001009369A3 Single-phase amplification of nucleic acids |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000075302A3 Isolation of nucleic acid |
| 04/26/2001 | WO2000073509A3 Molecules for diagnostics and therapeutics |
| 04/26/2001 | WO2000070353A3 High throughput assay systems and methods |
| 04/26/2001 | WO2000068423A3 Improved predictive power of rna analysis for protein expression |
| 04/26/2001 | WO2000066605A3 Polynucleotides |
| 04/26/2001 | WO2000063420A3 Biological fluid assay methods |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000060115A3 Method for identifying accessible binding sites on rna |
| 04/26/2001 | WO2000054581A3 Animal models and methods for sepsis |
| 04/26/2001 | WO2000052204A3 Gene expression in bladder tumors |
| 04/26/2001 | WO2000046585A3 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
| 04/26/2001 | WO2000011219A9 Subtle mitochondrial mutations as tumor markers |
| 04/26/2001 | WO2000003244A3 Immortalized human keratinocyte cell line |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |